Free Trial

FY2026 Earnings Estimate for AVR Issued By Cantor Fitzgerald

Anteris Technologies Global logo with Medical background

Anteris Technologies Global Corp (NASDAQ:AVR - Free Report) - Cantor Fitzgerald issued their FY2026 earnings estimates for shares of Anteris Technologies Global in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst R. Osborn expects that the company will post earnings of ($1.82) per share for the year. The consensus estimate for Anteris Technologies Global's current full-year earnings is ($2.66) per share.

Anteris Technologies Global Price Performance

NASDAQ AVR traded down $0.18 during trading hours on Wednesday, reaching $4.94. The company had a trading volume of 79,235 shares, compared to its average volume of 202,741. The firm has a 50-day moving average price of $4.05. Anteris Technologies Global has a 1-year low of $2.34 and a 1-year high of $8.79.

Anteris Technologies Global (NASDAQ:AVR - Get Free Report) last released its quarterly earnings data on Tuesday, May 13th. The company reported ($0.61) EPS for the quarter.

Hedge Funds Weigh In On Anteris Technologies Global

Hedge funds have recently made changes to their positions in the stock. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Anteris Technologies Global during the fourth quarter worth about $33,000. Corebridge Financial Inc. acquired a new stake in Anteris Technologies Global during the 1st quarter worth approximately $27,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new position in Anteris Technologies Global in the 1st quarter valued at approximately $32,000. Deutsche Bank AG acquired a new position in shares of Anteris Technologies Global in the first quarter worth $59,000. Finally, Nuveen LLC purchased a new stake in shares of Anteris Technologies Global during the first quarter worth $71,000.

Anteris Technologies Global Company Profile

(Get Free Report)

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

See Also

Should You Invest $1,000 in Anteris Technologies Global Right Now?

Before you consider Anteris Technologies Global, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anteris Technologies Global wasn't on the list.

While Anteris Technologies Global currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Defense Stocks Set to Crush the S&P This Summer
Analysts Are Watching These 4 Penny Stocks—You Should Too
Congress Is Pouring Millions Into These 6 Surprising Stocks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines